{"name":"Institut für Pharmakologie und Präventive Medizin","slug":"institut-f-r-pharmakologie-und-pr-ventive-medizin","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Olmesartan/Amlodipin","genericName":"Olmesartan/Amlodipin","slug":"olmesartan-amlodipin","indication":"Hypertension","status":"phase_3"},{"name":"Olmesartan/amlodipine","genericName":"Olmesartan/amlodipine","slug":"olmesartan-amlodipine","indication":"Hypertension","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Empagliflozin and Linagliptin","genericName":"Empagliflozin and Linagliptin","slug":"empagliflozin-and-linagliptin","indication":"Other","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Metformin and Insulin sc","genericName":"Metformin and Insulin sc","slug":"metformin-and-insulin-sc","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Empagliflozin and Linagliptin","genericName":"Empagliflozin and Linagliptin","slug":"empagliflozin-and-linagliptin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Metformin and Insulin sc","genericName":"Metformin and Insulin sc","slug":"metformin-and-insulin-sc","phase":"phase_3","mechanism":"Metformin works by decreasing glucose production in the liver and increasing insulin sensitivity, while insulin sc works by replacing or supplementing the body's natural insulin.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Olmesartan/Amlodipin","genericName":"Olmesartan/Amlodipin","slug":"olmesartan-amlodipin","phase":"phase_3","mechanism":"Olmesartan blocks angiotensin II receptors to lower blood pressure, while amlodipine blocks calcium channels to relax blood vessels and reduce cardiac workload.","indications":["Hypertension"],"catalyst":""},{"name":"Olmesartan/amlodipine","genericName":"Olmesartan/amlodipine","slug":"olmesartan-amlodipine","phase":"marketed","mechanism":"Olmesartan blocks angiotensin II receptors to lower blood pressure, while amlodipine blocks calcium channels to relax blood vessels and reduce cardiac workload.","indications":["Hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"marketed":2,"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}